UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Celltrion will use Oracle Health platform to streamline processes
by Marian Chu
2017-09-27 10:47
Can Celltrion, Samsung make stable earnings with biosimilar?
by Nam Doo-hyun
2017-09-26 17:31
Medifron aims high through R&D
by Lee Han-soo
2017-09-25 16:19
Korea lags far behind in biomedical R&D: report
by Nam Doo-hyun
2017-09-21 16:14
Biosimilar prescriptions fall by the wayside in Korea
by Marian Chu
2017-09-21 14:56
라인
Samsung Bioepis gets additional approval for its biosimilar
by Lee Hye-seon
2017-09-21 12:03
MSD dissolves promotion team for Samsung Bioepis’ biosimilars
by Lee Han-soo
2017-09-21 11:58
Sillajen emerges as biggest beneficiary of preferential listing
by Nam Doo-hyun
2017-09-20 17:22
Samsung Bioepis gets nods for phase 3 trials to treat macular degeneration
by Lee Han-soo
2017-09-19 17:39
Korean biopharmaceutical industry ranked 2nd among emerging countries
by Marian Chu
2017-09-19 10:37
라인
EU approvals for Samsung Bioepis push up share prices
by Nam Doo-hyun
2017-09-18 14:45
Genexin, Handok presents persistent growth hormone clinical trial results
by Lee Han-soo
2017-09-18 14:39
Celltrion in controversy over sexual harassment case
by Lee Han-soo
2017-09-15 18:11
‘Knowledge’ is core ability for bio industrialists, survey says
by Nam Doo-hyun
2017-09-15 16:28
Access Bio, PFSCM sign supply agreement for malaria kit
by Lee Han-soo
2017-09-15 14:52
라인
‘BIOplus Incheon 2017’ shares product-developing know-how
by Lee Han-soo
2017-09-14 11:14
Medipost to commercialize new stem cell-culture tech
by Constance Williams
2017-09-14 10:38
Hanall Biopharma made $81-million technology export to China
by Lee Hye-seon
2017-09-13 13:23
New VC investments in bio, medical fields fall sharpest in H1
by Nam Doo-hyun
2017-09-13 13:23
Celltrion presents Herzuma’s clinical results in Europe
by Lee Han-soo
2017-09-11 12:19
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top